BPC-157 and peptide stacks: separating gym hype from real science

What did @brian_dadbod2.0 actually say?

Brian made a set of overlapping claims about a compound called 5-Amino-1MQ (which he shortens to 5Mu1MQ, likely a character-substitution to dodge platform filters). He said users report "increased energy, improved glucose control, and visible changes in body composition within two weeks." He described it as having "evidence-backed results," a "novel, targeted approach to weight loss," and a "favorable safety profile." He also named specific contraindications, which is a level of medical specificity that most supplement creators skip entirely. He ended by directing viewers to his personal website to purchase the compound. That last part matters for context.

One claim got garbled in delivery. He mentioned "reduced added capability," which appears to be a transcript artifact of "reduced lipid accumulation" or a similar phrase, meaning whatever clinical framing he was reading from didn't make it to air cleanly. That's worth noting because it suggests the science communication here is secondhand at best.

Does the science back this up?

Partially, and with significant caveats. 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy metabolism. The mechanism is real and has legitimate research behind it, but almost exclusively in preclinical models.

The most cited work comes from Neelakantan et al. (2019, Nature Communications), which showed that NNMT inhibition in mice reduced fat mass, improved insulin sensitivity, and increased energy expenditure without changes to food intake. Those are genuinely interesting findings. However, mice are not humans, and no peer-reviewed human clinical trial on 5-Amino-1MQ has been published as of this writing. The "clinical findings" Brian references almost certainly means animal or cell studies, not human trials. Calling that "evidence-backed" without that qualifier is a meaningful stretch. The two-week human results he cites appear to come from anecdotal user reports and gray-market vendor documentation, not controlled research.

What did they get wrong (or right)?

Credit where it's due: Brian correctly identified NNMT inhibition as the mechanism of action. He also listed real contraindication categories. Pregnant or breastfeeding individuals, people with severe hepatic or renal impairment, and those on interacting medications are standard exclusion groups for experimental metabolic compounds. That's more responsible framing than you usually see in this category on TikTok.

What he got wrong is the evidence framing. Saying "clinical findings align with these observations" implies human clinical data exists and supports the user reports. It does not, at least not in the published literature. He also never clarified that 5-Amino-1MQ is an unscheduled research compound with no FDA approval, no established dosing safety data in humans, and no long-term safety studies of any kind. The phrase "evidence-backed results" applied to a compound with zero human trial data is misleading, full stop.

The referral link to his personal website to purchase a research compound creates a direct financial conflict of interest that he did not disclose. That's a problem regardless of what the science says.

What should you actually know?

5-Amino-1MQ is a legitimate area of metabolic research, but it is nowhere near ready to be marketed as a weight loss solution with "evidence-backed results." The gap between "interesting mouse data" and "safe for humans" is exactly where people get hurt by gray-market compounds.

NNMT plays a role in more than just fat metabolism. It's involved in liver function, methylation pathways, and has been studied in cancer biology contexts. Systemic NNMT inhibition in humans over time is not a well-characterized risk profile. The side effects Brian listed, mild GI discomfort and sleep disturbances, are speculative in the absence of human trial data. Serious adverse effects in a novel mechanism compound would not necessarily be predictable from animal work.

If you're interested in metabolic optimization, there are compounds with actual human trial data available through regulated telehealth. A licensed provider can walk you through what has and hasn't been studied in people. Buying a research compound from a creator's affiliate link after a TikTok video is not that process.